SAN FRANCISCO, Oct. 26, 2016 -- Hagens Berman Sobol Shapiro LLP reminds investors in Ferrellgas Partners L.P. (NYSE:FGP) of the December 5, 2016 Lead Plaintiff deadline in the securities class action lawsuit filed in the U.S. District Court for the Southern District of New York.
If you purchased or otherwise acquired FGP between June 1, 2015 and September 28, 2016 and suffered over $50,000 in losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/FGP
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
On September 28, 2016, Ferrellgas announced a net loss of approximately $665 million for fiscal 2016, a major reversal compared to the Company’s fiscal 2015 net profit of approximately $29 million. Ferrellgas’ President, CEO and director Stephen L. Warnbold resigned the same day without explanation.
Ferrellgas disclosed in its 2016 Form 10-K that its poor earnings were due mainly to $620 million in impairment charges from a June 2015 acquisition that were finally calculated and recorded in June 2016. The Company also announced its board may reduce the annual distribution rate to shareholders from $2.05 per common share to $1.00 per common share.
This news drove the Company’s price down over 21% to close at $13.00 on September 28, 2016. Nearly 6.4 million shares traded, or almost 16 times the average 10 day trading volume.
“Ferrellgas disclosed how it allocated and accounted for last year’s very large acquisition about three months ago. After seeing the numbers, investors now know most of the acquisition is worthless. We’re looking at those and other facts that inflicted damage on investors,” said Hagens Berman partner Reed Kathrein. “Defendants have offered no new words to sugarcoat the implosion and damage they’ve inflicted on investors.”
Whistleblowers: Persons with non-public information regarding Ferrellgas should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



